i-spy 2: advancing outcomes high-risk breast cancer through adapting therapies
Published 1 year ago • 351 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
7:26
i-spy 2: immunotherapy biomarkers in early breast cancer
-
2:15
i-spy2.2: emerging biomarkers in breast cancer
-
16:14
cancer early detection & interception panel part 4: i-spy 2 - breast cancer treatment
-
12:53
explanatory video about the i-spy 2 breast cancer clinical trial
-
0:58
dr. esserman gives an overview of the i-spy 2 trial
-
0:46
dr. esserman discusses the i-spy 2 trial
-
2:28
improving breast cancer treatment: incorporating immune predictors for better outcomes
-
22:42
paula pohlmann - precision medicine in the treatment of patients with breast cancer: i-spy trials
-
32:31
precision medicine in early stage breast cancer: the i-spy 2 experience: pgx conference 2018
-
2:01
i-spy 2 clinical trial for patients with stage 2 or 3 breast cancer
-
9:17
i-spy 2: durvalumab in combination with olaparib and paclitaxel in high-risk her2 negative stage...
-
15:33
hope s. rugo: first efficacy results from the i - spy 2 trial
-
31:38
accelerating knowledge turns: the i-spy model and drug development - laura esserman
-
14:29
i-spy trial: precision medicine and biomarket discovery for early stage breast cancer, by julia wulf
-
0:29
5 symptoms of breast cancer | warning signs of breast cancer | dr niharika garach
-
40:40
update of i-spy 2 for early-stage breast cancer
-
0:58
dr. esserman discusses the i-spy 2 trial in breast cancer
-
1:53
dr rita nanda discusses what findings of i-spy2 mean for future breast cancer treatments
-
39:40
prioritize your health: breast cancer risk and treatment